The medical significance of miniaturised or microscopic biological microarray chips, commonly known as biochips, has caused a revolutionising effect on the global healthcare industry. The global ICT and electronics sector has reaped benefits by incorporating latest scientific research in biochip technology into various medical fields such as bioinformatics or molecular biology. The wide range of biochip applications and products have catapulted the growth of the global biochips market size at a remarkable level.
The medical significance of miniaturised or microscopic biological microarray chips, commonly
known as biochips, has caused a revolutionising effect on the global healthcare industry. The
global ICT and electronics sector has reaped benefits by incorporating latest scientific research in
biochip technology into various medical fields such as bioinformatics or molecular biology. The
wide range of biochip applications and products have catapulted the growth of the global
biochips market size at a remarkable level.
The variable functionality of biochips is considered as a crucial advancement in medical
technology. Performing abundant calculations in a few seconds and assessing the gene-decoding
data by sending it to a computer quickly are the key features that have led to robust adoption of
The global biochips market value is set to increase at a substantial CAGR through 2020. The
principal trend driving the growth of the biochips market is their efficacy in identifying various
Recent research in biotechnology has proved the gravity of medical benefits deduced by the use
of biochips. The most crucial part of its medical approach is detection of cancerous cells and
restricting their metastasizing in bloodstreams.
The rising adoption of biochips as an integral component of cancer dialysis is inciting the growth
of its global market. The influence of digital microfluidic biochips is growing in several
biomedical fields, assisting the detection of bioterrorism agents and the analysis of gel-based
and plate-based DNA arrays.
Request Free Report [email protected] http://www.futuremarketinsights.com/reports/sample/rep-gb-
Drivers of the Global Biochips Market
Detection of Cancer & Other Diseases
Biochips are widely used to detect viral and bacterial agents that cause prevalent diseases such
as anthrax, plague and smallpox. Detecting malignant cells in the body of a cancer patient helps
the diagnosis in cancer treatments.
Personalisation of Medicine
Growth of personalised medicine has increased the demand for electronic biochips used for
medical analysis by individual consumers.
Less-invasive clinical procedures for installing biochips in the patient’s body are generating
higher adoption in global medical organisations. Improving diagnostic methods and lowering
expense through technical developments is also driving the demand for biochips.
Even though the benefits drawn from biochip use are way more conducive for the market’s
growth, there are a handful of compelling factors to limit the expanse of the global biochips
market. Lack of proper knowledge about biochip technology is a prominent restraint lowering
the demand for biochip products.
The irregularities arriving in healthcare coverage around the world are also more likely to
challenge the growth of biochips market. Variable cost and adoption of biochip technologies is
likely to affect the personalisation of medicine, eventually lowering the revenues of the global
Request For [email protected] http://www.futuremarketinsights.com/toc/rep-gb-212
To understand the biochip market outlook in depth, its global market is categorised into various
segments based on,
Middle East and Africa
Type of Applications
Drug Discovery & Development
Microarray Type (Product Type)
Biochips Market: Key Competitors
Companies such as Cepheid Inc., Sigma Aldrich Corp., EMD Milliproe, Calipher Life Sciences Inc.
and Agilent Technologies are some of the top players in the global market for biochips.
Affymetrix Inc., another leading biochip manufacturer, was the first company to introduce
commercial biochips called GeneChips. Redefining strategies involved in location of
manufacturing facilities, technology outsourcing, consumer base enhancement, and mergers
and alliances have helped shape up the competition in the global biochips market.
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
Weprovideresearchservicesat aglobalas wellas regionallevel;keyregionsincludeGCC, ASEAN,andBRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We
combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our
Social Media Research
Industrial Automation and Equipment
Healthcare, Pharmaceuticals & Medical Devices
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and
For detailed subscription information please contact
Hari. T (Sr. Manager -Global Business Development)
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Email: [email protected]
Thank You! syndicated research reports, custom research reports, and consulting
To know more about us, please visit our website:
For sales queries or new topics email us on:
For other queries contact:
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705